A drug with the SMILES CC#CCN1c2ccccc2[C@]23C[C@@H](C(=O)OC)N(C(=O)C4CCC4)C2=NC(C(=O)OC)=C(C(=O)OC)[C@H]13 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.175\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC#CCN1c2ccccc2[C@]23C[C@@H](C(=O)OC)N(C(=O)C4CCC4)C2=NC(C(=O)OC)=C(C(=O)OC)[C@H]13
CC#CCN1c2ccccc2[C@]23C[C@@H](C(=O)OC)N(C(=O)C4CCC4)C2=NC(C(=O)OC)=C(C(=O)OC)[C@H]13
trimethyl (1S,9R,15S)-8-but-2-ynyl-14-(cyclobutanecarbonyl)-8,12,14-triazatetracyclo[7.7.0.01,13.02,7]hexadeca-2,4,6,10,12-pentaene-10,11,15-tricarboxylate